Dados B3 › BRAV3 × PRIO3
BRAV3 × PRIO3
Indicators
Each row uses the most recent year in which BOTH companies have the figure, and says which year that is. A cell with ! carries a caveat — hover to read it. We do not name a winner: that would be a recommendation, and this site does not give any.
| indicator | BRAV3 | PRIO3 | year |
|---|---|---|---|
| ROE | 12.7% | 8.7% | 2025 |
| ROIC | 9.3% | 2.5%! | 2025 |
| ROA | 3.2% | 3.8% | 2025 |
| Gross margin | 26.7% | 20.0% | 2025 |
| EBIT margin | 19.1% | 11.6% | 2025 |
| Net margin | 12.1% | 14.4% | 2025 |
| Net debt/EBITDA | 2.39x | 3.27x | 2025 |
| Current ratio | 1.42x | 1.82x | 2025 |
| Revenue growth (1y) | 33.2% | 8.5% | 2025 |
| Revenue growth (5y CAGR) | 124.4% | 52.3% | 2025 |
| Piotroski F-Score | 7/9 | 4/9 | 2025 |
Point-in-time multiples
Priced at the first session on or after the day each filing became public — never the period close.
| indicator | BRAV3 | PRIO3 | year |
|---|---|---|---|
| P/E | 6.47x | 21.19x | 2025 |
| P/B | 0.77x | 1.85x | 2025 |
| EV/EBITDA | 4.39x | 9.49x | 2025 |
| FCF yield | 21.0% | 5.8% | 2025 |
Numbers on this page are live. Data version 2026-09-27-reapresentacao-agreg · page generated 2026-09-27 07:12 UTC. If this does not match /saude, you are reading a cached copy.
Sources: CVM (open data, ODbL) and B3 (COTAHIST). Not affiliated with B3 or the CVM. Not investment advice.
Numbers on this page are live. Data version 2026-09-27-reapresentacao-agreg · page generated 2026-09-27 07:12 UTC. If this does not match /saude, you are reading a cached copy.